AccessPak for HIV PEP Expanded with Kaletra and Empagliflozin and linagliptin
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Empagliflozin and linagliptin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Empagliflozin and metformin
- AccessPak for HIV PEP Expanded with Kaletra-Empagliflozin and Metformin Extended-Release Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Empagliflozin and Metformin Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Empliciti
- AccessPak for HIV PEP Expanded with Kaletra-Emsam
- AccessPak for HIV PEP Expanded with Kaletra-Emsam Transdermal
- Empagliflozin and linagliptin-AccessPak for HIV PEP Expanded with Viracept
- Empagliflozin and linagliptin-Accolate
- Empagliflozin and linagliptin-Accretropin
- Empagliflozin and linagliptin-Accucaine
- Empagliflozin and linagliptin-AccuHist Drops
- Empagliflozin and linagliptin-AccuHist PDX Drops